amrinone has been researched along with thromboxane a2 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonner, FW; Eason, CT; Pattison, A | 1 |
Levy, JH; Salmenperä, M | 1 |
Deschl, U; Platz, SJ; Schleger, C | 1 |
3 other study(ies) available for amrinone and thromboxane a2
Article | Year |
---|---|
The in vitro effect of amrinone on platelet aggregation in human whole blood.
Topics: Adenosine Diphosphate; Aminopyridines; Amrinone; Arachidonic Acid; Arachidonic Acids; Collagen; Humans; In Vitro Techniques; Male; Platelet Aggregation; Thromboxane A2 | 1986 |
The in vitro effects of phosphodiesterase inhibitors on the human internal mammary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amrinone; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Humans; Mammary Arteries; Milrinone; Norepinephrine; Papaverine; Phosphodiesterase Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Development of an in vitro model for vascular injury with human endothelial cells.
Topics: 3T3 Cells; Amrinone; Animal Testing Alternatives; Animals; Antibiotics, Antineoplastic; Antifibrinolytic Agents; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Electric Impedance; Endothelial Cells; Endothelium, Vascular; Epoprostenol; Humans; Immunosuppressive Agents; Injections, Intravenous; Mice; Mitomycin; Models, Biological; Phosphodiesterase Inhibitors; Rolipram; Thromboxane A2; Umbilical Veins; Vitamin K 3 | 2004 |